Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects (Q46539094)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2005

Language	Label	Description	Also known as
English	Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects	scientific article published in July 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

author name string

Raimund Margreiter

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Erich Pohanka

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Vito Sparacino

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Heide Sperschneider

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Ulrich Kunzendorf

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Walter Huber

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Norbert Lameire

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Vittorio E Andreucci

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Donato Donati

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Uwe Heemann

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

European Switch to Tacrolimus Study Group

11

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Transplant International

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

18

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

816-823

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Conversion from cyclosporin (Neoral) to tacrolimus (Prograf) in renal allograft recipients with chronic graft nephropathy: results of an observational study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Factors affecting renal allograft function in long-term recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Hyperlipidemia as a risk factor of renal allograft function impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00154.X

21 January 2018

Identifiers

10.1111/J.1432-2277.2005.00154.X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15948861

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46539094&oldid=2147768426"